Tickers

1. Composite Trajectory Verdict

Given IQV's acquisition-intensive services model, the income statement and cash flow statement carry the most weight for assessing operational profitability and cash generation, while the balance sheet reflects the financing of that growth.

Composite Trajectory: Mixed

Revenue has grown consistently on an annual basis (5.9% in 2025, 2.8% in 2024) and backlog/RPO expanded to $34.2B (10-K 2025-12-31, MD&A). However, operating income declined slightly in 2025 ($2,182M vs $2,202M in 2024) as cost of revenues rose faster than revenue (66.7% of revenue vs 65.1%) (10-K 2025-12-31, Consolidated Statements of Operations). Net income was flat ($1,361M vs $1,373M) and diluted EPS grew only due to share count reduction (10-K 2025-12-31, Consolidated Statements of Operations). Cash from operations dipped 2% in 2025 ($2,654M vs $2,716M) while debt principal increased $1.755B to $15.8B to fund $1.714B of acquisitions (10-K 2025-12-31, Consolidated Statements of Cash Flows; Note 10). The balance sheet shows leverage rising and goodwill increasing $1.9B, offset by equity growth from retained earnings.

2. Red Flags

• Cost of revenues (excl. D&A) as a percentage of revenue has risen each year: 65.0% (2023) → 65.1% (2024) → 66.7% (2025) (10-K 2025-12-31, Consolidated Statements of Operations).
• Operating income declined 0.9% in 2025 despite 5.9% revenue growth (10-K 2025-12-31, Consolidated Statements of Operations).
• Interest expense increased 8.8% to $729M in 2025 while operating income fell (10-K 2025-12-31, Consolidated Statements of Operations).
• Total debt principal rose $1.755B (12.5%) to $15.8B in 2025, driven by $2.0B senior notes issuance and term loan refinancing (10-K 2025-12-31, Note 10).
• Cash from operations decreased $62M in 2025, with working capital changes showing $211M more cash used for accounts payable/accrued expenses and $144M more for income tax/other payables (10-K 2025-12-31, MD&A Liquidity).
• Restructuring costs jumped 57% to $105M in 2025, with actions expected to continue into 2026 (10-K 2025-12-31, MD&A; Note 15).
• Net unbilled services/unearned income balance swung from a $77M asset to a $335M liability, a $412M negative shift driven by R&D Solutions milestone billing timing (10-K 2025-12-31, Note 3).
• Noncontrolling interest of $127M appeared on the balance sheet in 2025 from zero in 2024, related to acquisitions (10-K 2025-12-31, Consolidated Balance Sheets; Note 14).
• Effective tax rate volatile: 6.9% (2023) → 18.0% (2024) → 15.8% (2025) (10-K 2025-12-31, Consolidated Statements of Operations).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual revenue grew 5.9% to $16.31B in 2025 (10-K 2025-12-31, Consolidated Statements of Operations), with all three segments contributing: TAS +7.6% to $6.63B, RDS +4.3% to $8.90B, CSMS +9.7% to $788M (10-K 2025-12-31, MD&A Segment Results). However, operating income slipped to $2.182B from $2.202B as cost of revenues rose 8.5% ($850M) versus 5.9% revenue growth ($905M) (10-K 2025-12-31, Consolidated Statements of Operations). SG&A improved as a percentage of revenue (12.3% vs 12.9%) but restructuring costs rose to $105M (10-K 2025-12-31, MD&A). Net income was essentially flat at $1.361B vs $1.373B; diluted EPS rose to $7.84 from $7.49 solely due to a 5.4% reduction in diluted shares outstanding from buybacks (10-K 2025-12-31, Consolidated Statements of Operations; Note 21). RDS segment profit fell 3.9% to $1.873B despite revenue growth, as cost of revenues grew 7.5% (10-K 2025-12-31, MD&A Segment Results).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Cash from operations reached $2.654B in 2025, down 2% from $2.716B in 2024 but up 24% from $2.149B in 2023 (10-K 2025-12-31, Consolidated Statements of Cash Flows). The 2025 decline was driven by $211M more cash used for accounts payable/accrued expenses, $144M more for income tax/other payables, and $122M less from receivables/unbilled services, partially offset by $233M more from unearned income (10-K 2025-12-31, MD&A Liquidity). Capital expenditures were stable at ~$603M annually (10-K 2025-12-31, Consolidated Statements of Cash Flows). Acquisitions consumed $1.714B in 2025 vs $735M in 2024 (10-K 2025-12-31, Consolidated Statements of Cash Flows). Free cash flow (CFO minus capex) was ~$2.05B in 2025 vs ~$2.11B in 2024. Financing cash flow was -$150M in 2025 vs -$878M in 2024, as $6.465B debt proceeds largely offset $5.193B debt repayments and $1.244B share repurchases (10-K 2025-12-31, Consolidated Statements of Cash Flows). Cash balance grew to $1.98B from $1.70B (10-K 2025-12-31, Consolidated Balance Sheets).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Total assets grew 11% to $29.9B in 2025, but liabilities grew 12% to $23.3B, outpacing equity growth of 9% to $6.63B (10-K 2025-12-31, Consolidated Balance Sheets). Goodwill surged $1.9B to $16.6B (11% of assets) from acquisitions (10-K 2025-12-31, Note 8). Total debt principal increased $1.755B to $15.8B; current portion of long-term debt rose 61% to $1.84B (10-K 2025-12-31, Note 10). Unearned income grew 19% to $2.12B, contributing to a $1.38B increase in current liabilities (10-K 2025-12-31, Consolidated Balance Sheets; Note 3). Accumulated other comprehensive loss widened to -$943M from -$1.038B, driven by foreign currency translation (10-K 2025-12-31, Consolidated Statements of Comprehensive Income). Treasury stock increased to $11.36B (89.5M shares) from $10.10B (82.1M shares) (10-K 2025-12-31, Consolidated Statements of Stockholders' Equity). The senior secured net leverage covenant remains in compliance (10-K 2025-12-31, MD&A Liquidity).

6. Data Gaps

• Quarterly GAAP financial statements (income statement, cash flows, balance sheet) for Q1 2026, Q2 2026, Q3 2025, Q2 2025 are not present in the provided 10-Q filings (only MD&A introductions included).
• Segment revenue and profit recast for the new Commercial Solutions and R&D Solutions segments effective Jan 1, 2026.
• Constant currency growth rates for quarterly periods.
• Detailed breakdown of "general corporate and unallocated expenses" for quarterly periods.
• Quarterly interest expense and debt maturity schedule for 2026.
• Quarterly restructuring charges and remaining accrual balances.
• Quarterly share repurchase amounts and average prices.